The company informed the bourses that it allocated 4,071, 634 equity shares at Rs 344 per share to anchor investors.
FinTech BizNews Service
Mumbai, 14 October 2026: Sahajanand Medical Technologies Limited, which is a is a Class III and Class C/D medical devices company with a portfolio of technologically advanced medical devices across vascular and structural heart intervention, has garnered Rs 140 crore from anchor investors ahead of its initial public offering, which opens for public subscription on Thursday, October 15, 2026.
The company informed the bourses that it allocated 4,071, 634 equity shares at Rs 344 per share to anchor investors.
Some of the marquee institutions that participated in the anchor include Allianz Global Investors Fund – Allianz India Equity, Natixis International Funds (Lux) I – Loomis Sayles Global Emerging Markets Equity Fund and Tata AIA Life Insurance Company Limited A/C Whole Life Aggressive Growth Fund ULIF.
Amongst equity- oriented schemes, the company has allocated shares to DSP Healthcare Fund, Nippon Life India Trustee Ltd – A/C Nippon India Small Cap Fund and Whiteoak Capital Flexi Cap Fund, amongst others.
Out of the total allocation of 4,071, 634 equity shares to the anchor investors, 3,025,093 were allocated to 5 domestic mutual funds through 7 schemes.
Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited are the book-running lead managers, and MUFG Intime India Private Limited is the registrar of the offer.
The equity shares are proposed to be listed on NSE and BSE.
IPO Details
Sahajanand Medical Technologies Limited has fixed the price band of Rs 327 to Rs 344 per Equity Share of face value Rs. 1/- each for its maiden initial public offer.
The Initial Public Offering (“IPO” or “Offer”) of the Company will open on Thursday, October 15, 2026, for subscription and close on Monday, October 19, 2026.
Investors can bid for a minimum of 43 Equity Shares and in multiples of 43 Equity Shares thereafter.
The offer, with a face value of Rs 1 per equity share, is an offer-for-sale for up to 13,822,116 equity shares by promoters - Shree Hari Trust and Dhirajkumar Savjibhai Vasoya.
Investors selling shares - Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B.V.
The Offer is being made through the book-building process, in compliance with SEBI ICDR Regulations, wherein not more than 50% of the net offer will be available for allocation to qualified institutional buyers (QIBs), not less than 15% to non-institutional bidders (NIIs), and not less than 35% to retail individual bidders (RIIs).
